CorVel (CRVL) Competitors $82.79 -2.80 (-3.27%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$82.86 +0.06 (+0.08%) As of 09/15/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRVL vs. DVA, CHE, AMED, MD, AMN, CCRN, LH, DGX, APG, and RTOShould you be buying CorVel stock or one of its competitors? The main competitors of CorVel include DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), APi Group (APG), and Rentokil Initial (RTO). CorVel vs. Its Competitors DaVita Chemed Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Labcorp Quest Diagnostics APi Group Rentokil Initial CorVel (NASDAQ:CRVL) and DaVita (NYSE:DVA) are both mid-cap health care services companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk. Which has more volatility & risk, CRVL or DVA? CorVel has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, DaVita has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Which has stronger valuation & earnings, CRVL or DVA? DaVita has higher revenue and earnings than CorVel. DaVita is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCorVel$895.59M4.74$95.17M$1.9442.68DaVita$12.82B0.73$936.34M$10.1712.88 Do institutionals and insiders believe in CRVL or DVA? 51.4% of CorVel shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 44.6% of CorVel shares are held by company insiders. Comparatively, 1.5% of DaVita shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is CRVL or DVA more profitable? CorVel has a net margin of 10.98% compared to DaVita's net margin of 6.35%. DaVita's return on equity of 369.39% beat CorVel's return on equity.Company Net Margins Return on Equity Return on Assets CorVel10.98% 32.31% 18.33% DaVita 6.35%369.39%4.62% Do analysts rate CRVL or DVA? DaVita has a consensus target price of $158.00, indicating a potential upside of 20.66%. Given DaVita's stronger consensus rating and higher probable upside, analysts clearly believe DaVita is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00DaVita 1 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.75 Does the media refer more to CRVL or DVA? In the previous week, DaVita had 2 more articles in the media than CorVel. MarketBeat recorded 16 mentions for DaVita and 14 mentions for CorVel. DaVita's average media sentiment score of 0.85 beat CorVel's score of 0.75 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 6 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 7 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDaVita beats CorVel on 10 of the 15 factors compared between the two stocks. Get CorVel News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRVL vs. The Competition Export to ExcelMetricCorVelBUSINESS SVCS IndustryBusiness SectorNASDAQ ExchangeMarket Cap$4.39B$5.64B$26.33B$10.16BDividend YieldN/A3.27%2.75%4.60%P/E Ratio42.6827.8326.9326.39Price / Sales4.741.791,207.87177.24Price / Cash35.2516.0725.8729.91Price / Book13.204.607.706.28Net Income$95.17M$156.87M$199.11M$270.38M7 Day Performance-5.45%-1.01%3.47%1.89%1 Month Performance-6.16%-2.62%20.19%6.01%1 Year Performance-22.63%51.79%49.63%25.26% CorVel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVLCorVel2.0955 of 5 stars$82.79-3.3%N/A-21.6%$4.39B$895.59M42.685,075DVADaVita4.6487 of 5 stars$134.44-2.5%$164.00+22.0%-19.9%$9.86B$12.82B13.2276,000Analyst UpgradeCHEChemed4.9986 of 5 stars$464.58-0.2%$592.25+27.5%-23.0%$6.79B$2.43B23.8915,695Positive NewsShort Interest ↓AMEDAmedisys2.0435 of 5 stars$101.01+0.0%$100.50-0.5%+4.2%$3.32B$2.40B39.3020,000MDPediatrix Medical Group2.1755 of 5 stars$16.95-0.7%$16.79-1.0%+51.5%$1.49B$2.01B13.144,305Analyst DowngradeAMNAMN Healthcare Services4.642 of 5 stars$20.97+0.6%$28.25+34.7%-61.4%$799.06M$2.98B-2.702,968Short Interest ↓CCRNCross Country Healthcare3.5901 of 5 stars$14.05-0.4%$17.93+27.6%-7.1%$461.94M$1.34B-54.048,205Positive NewsLHLabcorp4.7027 of 5 stars$276.99-0.6%$290.33+4.8%+24.5%$23.16B$13.01B30.5770,000Positive NewsDGXQuest Diagnostics4.7707 of 5 stars$182.53-0.5%$186.00+1.9%+17.1%$20.52B$9.87B21.8656,000Positive NewsAPGAPi Group2.9262 of 5 stars$35.16+0.6%$36.10+2.7%+53.6%$14.54B$7.02B109.8629,000Positive NewsRTORentokil Initial1.5794 of 5 stars$25.96+1.6%N/A+0.1%$12.91B$6.95B17.1968,485Positive News Related Companies and Tools Related Companies DVA Alternatives CHE Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives LH Alternatives DGX Alternatives APG Alternatives RTO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRVL) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorVel Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorVel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
